Table of Content

1 INTRODUCTION (Page No. - 24)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
                    FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET
                    FIGURE 2 REGIONAL SEGMENTS COVERED
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY CONSIDERED
          TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
    1.4 STAKEHOLDERS
    1.5 LIMITATIONS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 28)
    2.1 RESEARCH DATA
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Insights from primary experts
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
                    FIGURE 7 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
                    FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
           2.2.2 APPROACH 2: TOP-DOWN APPROACH (SUPPLY SIDE ANALYSIS)
                    FIGURE 9 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RISK ASSESSMENT
          TABLE 2 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET

3 EXECUTIVE SUMMARY (Page No. - 40)
    FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 44)
    4.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW
          FIGURE 15 NEED TO CURTAIL ESCALATING HEALTHCARE COSTS TO DRIVE MARKET
    4.2 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER AND COUNTRY (2021)
          FIGURE 16 JAPAN DOMINATED ASIA PACIFIC MARKET IN 2021
    4.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 REGIONAL MIX: POPULATION HEALTH MANAGEMENT MARKET (2022−2027)
          FIGURE 18 NORTH AMERICA TO DOMINATE GLOBAL MARKET DURING FORECAST PERIOD
    4.5 POPULATION HEALTH MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS
          FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
          FIGURE 20 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Government mandates and support for healthcare IT solutions
                    5.2.1.2 Need to curtail escalating healthcare costs
                                FIGURE 21 US HEALTHCARE SPENDING, 2012–2020 (USD BILLION)
                    5.2.1.3 Rising geriatric population and subsequent growth in chronic disease burden
           5.2.2 RESTRAINTS
                    5.2.2.1 High investments in infrastructure to set up robust PHM program
                    5.2.2.2 Rising data breach concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing importance of emerging markets in healthcare sector
                    5.2.3.2 Rising focus on personalized medicine
                    5.2.3.3 Increasing focus on value-based medicine
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of data management capabilities and skilled analysts
                    5.2.4.2 Interoperability issues

6 INDUSTRY INSIGHTS (Page No. - 57)
    6.1 INDUSTRY TRENDS
           6.1.1 NEED FOR INTEROPERABILITY AND INTEGRATION TO DRIVE INNOVATION
           6.1.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
           6.1.3 GROWING DEMAND FOR PATIENT-CENTRIC HEALTHCARE
                    FIGURE 22 VALUE-BASED CARE WORKFLOW
           6.1.4 CLOUD-BASED IT SOLUTIONS
           6.1.5 CONSOLIDATION OF HEALTHCARE PROVIDERS
    6.2 ECOSYSTEM ANALYSIS
        FIGURE 23 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
    6.3 EVOLUTION OF ACOS: A PROMISING PAYMENT REFORM
           6.3.1 INTRODUCTION
                    FIGURE 24 ACOS: REIMBURSEMENT MODEL
           6.3.2 US: EVOLUTION OF ACOS
                    FIGURE 25 EVOLUTION OF ACO MODELS
           6.3.3 ROLE OF INFORMATION TECHNOLOGY IN ACCOUNTABLE CARE
                    FIGURE 26 ACCOUNTABLE CARE SOLUTIONS AND THEIR USE
    6.4 HCIT EXPENDITURE ANALYSIS
           6.4.1 NORTH AMERICA
                    TABLE 4 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY
           6.4.2 EUROPE
           6.4.3 ASIA PACIFIC
                    TABLE 5 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING
                    TABLE 6 CHINA: HEALTHCARE IT INITIATIVES AND FUNDING
    6.5 REGULATORY ANALYSIS
           6.5.1 NORTH AMERICA
           6.5.2 EUROPE
           6.5.3 ASIA PACIFIC
    6.6 PORTER’S FIVE FORCES ANALYSIS
          FIGURE 27 DEGREE OF COMPETITION TO BE HIGH IN POPULATION HEALTH MANAGEMENT MARKET
          TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
    6.7 PATENT ANALYSIS
          FIGURE 28 TOP PATENT OWNERS AND APPLICANTS FOR POPULATION HEALTH MANAGEMENT SOLUTIONS (JANUARY 2011–SEPTEMBER 2022)
          FIGURE 29 PATENT ANALYSIS: POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2017–SEPTEMBER 2022)
    6.8 ADJACENT MARKET ANALYSIS
          FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET: MARKET OVERVIEW
          FIGURE 31 AMBULATORY EHR MARKET: MARKET OVERVIEW
    6.9 CASE STUDY
    6.10 KEY STAKEHOLDERS AND BUYING CRITERIA
           6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
                     TABLE 8 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR DEPLOYMENT MODES (%)
           6.10.2 BUYING CRITERIA
                     FIGURE 33 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
                     TABLE 9 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
    6.11 KEY CONFERENCES AND EVENTS (2022-2023)
    6.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           FIGURE 34 REVENUE SHIFT IN POPULATION HEALTH MANAGEMENT MARKET
    6.13 PRICING ANALYSIS
           6.13.1 INITIAL FEES
                     TABLE 10 PRE-ELEMENT FEE FOR PHM SOLUTIONS
           6.13.2 ANNUAL MAINTENANCE FEES
                     TABLE 11 ANNUAL MAINTENANCE FEE FOR PHM SOLUTIONS
    6.14 TECHNOLOGY ANALYSIS
           6.14.1 INTEGRATION OF AI AND ML
           6.14.2 DATA ANALYTICS

7 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT (Page No. - 80)
    7.1 INTRODUCTION
          TABLE 12 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
    7.2 SOFTWARE
           7.2.1 SOFTWARE TO DOMINATE COMPONENT SEGMENT
                    TABLE 13 POPULATION HEALTH MANAGEMENT SOFTWARE OFFERED BY KEY PLAYERS
                    TABLE 14 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 SERVICES
           7.3.1 INDISPENSABLE AND RECURRING NATURE OF SERVICES TO PROPEL MARKET
                    TABLE 15 POPULATION HEALTH MANAGEMENT SERVICES OFFERED BY KEY PLAYERS
                    TABLE 16 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

8 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY (Page No. - 88)
    8.1 INTRODUCTION
          TABLE 17 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
    8.2 ON-PREMISE MODE OF DELIVERY
           8.2.1 TRADITIONAL ON-PREMISE DEPLOYMENT TO ALLOW TIME TO TEST SOFTWARE UPGRADES BEFORE IMPLEMENTATION
                    TABLE 18 ON-PREMISE MODE OF DELIVERY: PROS AND CONS
                    TABLE 19 POPULATION HEALTH MANAGEMENT MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 CLOUD-BASED MODE OF DELIVERY
           8.3.1 CLOUD-BASED DELIVERY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
                    TABLE 20 CLOUD-BASED MODE OF DELIVERY: PROS AND CONS
                    TABLE 21 POPULATION HEALTH MANAGEMENT MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)

9 POPULATION HEALTH MANAGEMENT MARKET, BY END USER (Page No. - 93)
    9.1 INTRODUCTION
          TABLE 22 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 HEALTHCARE PROVIDERS
           9.2.1 NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST MARKET
                    TABLE 23 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 HEALTHCARE PAYERS
           9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO STIMULATE DEMAND FOR PHM SOLUTIONS
                    TABLE 24 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 OTHER END USERS
          TABLE 25 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)

10 POPULATION HEALTH MANAGEMENT MARKET, BY REGION (Page No. - 99)
     10.1 INTRODUCTION
             TABLE 26 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 35 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
             TABLE 27 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 28 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 29 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
             TABLE 30 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 US to dominate North American market during forecast period
                                      TABLE 31 US: MACROECONOMIC INDICATORS
                                      TABLE 32 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 33 US: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 34 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Deployment of digital health initiatives to boost market
                                      TABLE 35 CANADA: MACROECONOMIC INDICATORS
                                      TABLE 36 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 37 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 38 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.3 EUROPE
             TABLE 39 EUROPE: E-HEALTH PRIORITIES FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019
             TABLE 40 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 41 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 42 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
             TABLE 43 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Germany to dominate European population health management market
                                      TABLE 44 GERMANY: MACROECONOMIC INDICATORS
                                      TABLE 45 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 46 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 47 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Increasing public-private initiatives to support adoption of PHM solutions
                                      TABLE 48 UK: MACROECONOMIC INDICATORS
                                      TABLE 49 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 50 UK: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 51 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Increasing patient volume for chronic and age-related conditions to fuel market
                                      TABLE 52 FRANCE: MACROECONOMIC INDICATORS
                                      TABLE 53 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 54 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 55 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Government initiatives to support market
                                      TABLE 56 ITALY: MACROECONOMIC INDICATORS
                                      TABLE 57 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 58 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 59 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Demand for e-prescriptions and better patient record management to drive adoption of PHM solutions
                                      TABLE 60 SPAIN: MACROECONOMIC INDICATORS
                                      TABLE 61 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 62 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 63 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 64 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 65 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                        TABLE 66 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 36 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
             TABLE 67 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 68 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 69 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
             TABLE 70 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Japan accounted for largest share of Asia Pacific market in 2021
                                      TABLE 71 JAPAN: MACROECONOMIC INDICATORS
                                      TABLE 72 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 73 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 74 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Strong government support to propel market
                                      TABLE 75 CHINA: MACROECONOMIC INDICATORS
                                      TABLE 76 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 77 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 78 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Growing volume of patient data generated within healthcare systems to drive market
                                      TABLE 79 INDIA: MACROECONOMIC INDICATORS
                                      TABLE 80 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 81 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 82 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                        TABLE 83 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 84 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                        TABLE 85 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA
             10.5.1 BRAZIL, ARGENTINA, AND MEXICO TO EMERGE AS POTENTIAL HEALTHCARE MARKETS
                        TABLE 86 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 87 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                        TABLE 88 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE TO PROPEL MARKET
                        TABLE 89 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 90 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                        TABLE 91 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 138)
     11.1 INTRODUCTION
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             FIGURE 37 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2019 AND AUGUST 2022
     11.3 POPULATION HEALTH MANAGEMENT MARKET: R&D EXPENDITURE
             FIGURE 38 R&D EXPENDITURE OF KEY PLAYERS (2020 VS. 2021)
     11.4 REVENUE ANALYSIS OF KEY PLAYERS
             FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS (2021)
     11.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
             FIGURE 40 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC REVENUE MIX
     11.6 COMPANY EVALUATION QUADRANT
             11.6.1 STARS
             11.6.2 EMERGING LEADERS
             11.6.3 PERVASIVE PLAYERS
             11.6.4 PARTICIPANTS
                        FIGURE 41 COMPETITIVE LEADERSHIP MAPPING, 2020
     11.7 COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 RESPONSIVE COMPANIES
             11.7.3 DYNAMIC COMPANIES
             11.7.4 STARTING BLOCKS
                        FIGURE 42 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
     11.8 KEY PLAYERS ANALYSIS
             TABLE 92 POPULATION HEALTH MANAGEMENT MARKET ANALYSIS, BY VENDOR TYPE
     11.9 COMPETITIVE SITUATIONS AND TRENDS
             11.9.1 PRODUCT LAUNCHES
             11.9.2 DEALS
             11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 151)
     12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 CERNER CORPORATION
                        TABLE 93 CERNER CORPORATION: COMPANY OVERVIEW
                        FIGURE 43 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.2 ALLSCRIPTS HEALTHCARE SOLUTIONS
                        TABLE 94 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY OVERVIEW
                        FIGURE 44 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2021)
             12.1.3 IBM CORPORATION
                        TABLE 95 IBM CORPORATION: COMPANY OVERVIEW
                        FIGURE 45 IBM CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.4 EPIC SYSTEMS CORPORATION
                        TABLE 96 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
             12.1.5 KONINKLIJKE PHILIPS
                        TABLE 97 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 46 PHILLIPS HEALTHCARE: COMPANY SNAPSHOT (2021)
             12.1.6 I2I POPULATION HEALTH
                        TABLE 98 I2I POPULATION HEALTH: COMPANY OVERVIEW
             12.1.7 HEALTH CATALYST
                        TABLE 99 HEALTH CATALYST: COMPANY OVERVIEW
                        FIGURE 47 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
             12.1.8 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP)
                        TABLE 100 OPTUM, INC: COMPANY OVERVIEW
                        FIGURE 48 OPTUM: COMPANY SNAPSHOT (2021)
             12.1.9 ENLI HEALTH INTELLIGENCE (A CEDAR GROUP TECHNOLOGIES)
                        TABLE 101 ENLI HEALTH INTELLIGENCE: COMPANY OVERVIEW
             12.1.10 ECLINICALWORKS
                        TABLE 102 ECLINICALWORKS: COMPANY OVERVIEW
             12.1.11 HEALTHEC, LLC
                        TABLE 103 HEALTHEC LLC: COMPANY OVERVIEW
             12.1.12 MEDECISION
                        TABLE 104 MEDECISION: COMPANY OVERVIEW
             12.1.13 ARCADIA
                        TABLE 105 ARCADIA: COMPANY OVERVIEW
             12.1.14 ATHENAHEALTH
                        TABLE 106 ATHENAHEALTH, INC: COMPANY OVERVIEW
             12.1.15 COTIVITI (VERSCEND TECHNOLOGIES)
                        TABLE 107 COTIVITI: COMPANY OVERVIEW
             12.1.16 NEXTGEN HEALTHCARE, INC.
                        TABLE 108 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
                        FIGURE 49 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2021)
     12.2 OTHER PLAYERS
             12.2.1 CONIFER HEALTH SOLUTIONS
             12.2.2 SPH ANALYTICS
             12.2.3 LIGHTBEAM HEALTH SOLUTIONS
             12.2.4 INNOVACCER
             12.2.5 LUMERIS
             12.2.6 ZEOMEGA
             12.2.7 HGS HEALTHCARE, LLC
             12.2.8 PERSIVIA
             12.2.9 COLOR HEALTH, INC.

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 199)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS